Analysts Issue Forecasts for PTCT Q1 Earnings
PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) – Analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for PTC Therapeutics in a research note issued on Friday, February 28th. William Blair analyst S. Corwin forecasts that the biopharmaceutical company will earn ($0.57) per share for the quarter. The consensus estimate for […]
